prof. dr. Michel Langlois
No current affiliation with UGent
Show
Sort by
-
Update on apolipoprotein B
-
The CCA special issue on cardiovascular markers
-
How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study
-
- Journal Article
- A1
- open access
Quantifying atherogenic lipoproteins for lipid-lowering strategies : consensus-based recommendations from EAS and EFLM
-
Non-HDL cholesterol or apoB : which to prefer as a target for the prevention of atherosclerotic cardiovascular disease?
-
Investigations on the clinical utility of apolipoprotein B measurement : a research priority
-
Evolving concepts on the management of dyslipidaemia
-
Muscle strength is a major determinant of the blood pressure response to isometric stress testing : the Asklepios population study
-
Quantifying atherogenic lipoproteins : current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol : a consensus statement from EAS and EFLM
-
Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis